Eikon Therapeutics Inc (EIKN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 866 |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
1 |
$1,031,045 |
| Sells |
0 |
$0 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 08 Sep 2026 |
COLUMN GROUP IV GP, LP |
10% |
03 Sep 2026 |
89,200 |
11.56 |
1,031,045 |
| 09 Feb 2026 |
COLUMN GROUP IV GP, LP |
10% |
06 Feb 2026 |
1,437,323 |
18.00 |
25,871,814 |
| 09 Feb 2026 |
COLUMN GROUP IV GP, LP |
10% |
06 Feb 2026 |
630,881 |
18.00 |
11,355,858 |
| 09 Feb 2026 |
COLUMN GROUP IV GP, LP |
10% |
06 Feb 2026 |
49,556 |
18.00 |
892,008 |
| 06 Feb 2026 |
FORESITE CAPITAL MANAGEMENT IV, LLC |
10% |
04 Feb 2026 |
55,555 |
18.00 |
999,990 |
| 06 Feb 2026 |
FRAZIER KENNETH C |
Director |
04 Feb 2026 |
111,111 |
18.00 |
1,999,998 |
| 06 Feb 2026 |
WOLFE JOSH |
Director , 10% |
04 Feb 2026 |
138,888 |
18.00 |
2,499,984 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock